ArticlePharmaceuticals (Basel, Switzerland)2022

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [

Oliver Clauß et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.